Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

by Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher
Published 2018

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

by Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher
Published 2018

One month of rifapentine plus isoniazid to prevent HIV-related Tuberculosis

by Susan Swindells, Ritesh Ramchandani, Amita Gupta, Constance A. Benson, Jorge Leon-Cruz, Noluthando Mwelase, Marc A. Jean Juste, Javier R. Lama, Javier Valencia, Ayotunde Omoz-Oarhe, Khuanchai Supparatpinyo, Gaerolwe Masheto, Lerato Mohapi, Rodrigo O. Da Silva Escada, Sajeeda Mawlana, Peter Banda, Patrice Severe, James Hakim, Cecilia Kanyama, Deborah Langat, Laura Moran, Janet Andersen, Courtney V. Fletcher, Eric Nuermberger, Richard E. Chaisson
Published 2019

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial

by Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo, Susan Swindells, Joseph Eron, Ying Q. Chen, Lei Wang, San San Ou, Maija Anderson, Marybeth McCauley, Theresa Gamble, Nagalingeshwaran Kumarasamy, James G. Hakim, Johnstone Kumwenda, Jose H.S. Pilotto, Sheela V. Godbole, Suwat Chariyalertsak, Marineide Gonçalves De Melo, Kenneth H. Mayer, Susan H. Eshleman, Estelle Piwowar-Manning, Joseph Makhema, Lisa A. Mills, Ravindre Panchia, Ian Sanne, Joel Gallant, Irving Hoffman, Taha E. Taha, Karin Nielsen-Saines, David Celentano, Max Essex, Diane Havlir, Myron S. Cohen
Published 2018

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial

by Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo, Susan Swindells, Joseph Eron, Ying Q. Chen, Lei Wang, San San Ou, Maija Anderson, Marybeth McCauley, Theresa Gamble, Nagalingeshwaran Kumarasamy, James G. Hakim, Johnstone Kumwenda, Jose H.S. Pilotto, Sheela V. Godbole, Suwat Chariyalertsak, Marineide Gonçalves De Melo, Kenneth H. Mayer, Susan H. Eshleman, Estelle Piwowar-Manning, Joseph Makhema, Lisa A. Mills, Ravindre Panchia, Ian Sanne, Joel Gallant, Irving Hoffman, Taha E. Taha, Karin Nielsen-Saines, David Celentano, Max Essex, Diane Havlir, Myron S. Cohen
Published 2018

Prevention of HIV-1 infection with early antiretroviral therapy

by Myron S. Cohen, Ying Q. Chen, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James G. Hakim, Johnstone Kumwenda, Beatriz Grinsztejn, Jose H.S. Pilotto, Sheela V. Godbole, Sanjay Mehendale, Suwat Chariyalertsak, Breno R. Santos, Kenneth H. Mayer, Irving F. Hoffman, Susan H. Eshleman, Estelle Piwowar-Manning, Lei Wang, Joseph Makhema, Lisa A. Mills, Guy De Bruyn, Ian Sanne, Joseph Eron, Joel Gallant, Diane Havlir, Susan Swindells, Heather Ribaudo, Vanessa Elharrar, David Burns, Taha E. Taha, Karin Nielsen-Saines, David Celentano, Max Essex, Thomas R. Fleming
Published 2018